FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
COVENTRY HEALTH CARE INC [ CVH ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 11/01/2007 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 11/01/2007 | S | 100 | D | $59.975 | 240,891(1) | D(2) | |||
Common Stock | 11/01/2007 | S | 1,491 | D | $59.98 | 239,400(3) | D(4) | |||
Common Stock | 11/01/2007 | S | 1,900 | D | $59.99 | 237,500(5) | D(6) | |||
Common Stock | 11/01/2007 | S | 300 | D | $60 | 237,200(7) | D(8) | |||
Common Stock | 11/01/2007 | S | 100 | D | $60.01 | 237,100(9) | D(10) | |||
Common Stock | 11/01/2007 | S | 500 | D | $60.02 | 236,600(11) | D(12) | |||
Common Stock | 11/01/2007 | S | 400 | D | $60.03 | 236,200(13) | D(14) | |||
Common Stock | 11/01/2007 | S | 200 | D | $60.04 | 236,000(15) | D(16) | |||
Common Stock | 11/01/2007 | S | 900 | D | $60.05 | 235,100(17) | D(18) | |||
Common Stock | 11/01/2007 | S | 100 | D | $60.065 | 235,000(19) | D(20) | |||
Common Stock | 11/01/2007 | S | 600 | D | $60.07 | 234,400(21) | D(22) | |||
Common Stock | 11/01/2007 | S | 100 | D | $60.08 | 234,300(23) | D(24) | |||
Common Stock | 11/01/2007 | S | 300 | D | $60.085 | 234,000(25) | D(26) | |||
Common Stock | 11/01/2007 | S | 100 | D | $60.09 | 233,900(27) | D(28) | |||
Common Stock | 11/01/2007 | S | 200 | D | $60.095 | 233,700(29) | D(30) | |||
Common Stock | 11/01/2007 | S | 800 | D | $60.11 | 232,900(31) | D(32) | |||
Common Stock | 11/01/2007 | S | 100 | D | $60.18 | 232,800(33) | D(34) | |||
Common Stock | 11/01/2007 | S | 300 | D | $60.21 | 232,500(35) | D(36) |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
1. Includes the following Table I Non-Derivative Securities: 8,391 shares held directly; 6,875 shares held indirectly by managed account (401(k) Plan); and 225,625 shares of restricted common stock with restrictions releasing in equal annual increments over three- and four-year periods, held directly. |
2. See Footnote 1 for shares held directly and indirectly. |
3. Includes the following Table I Non-Derivative Securities: 6,900 shares held directly; 6,875 shares held indirectly by managed account (401(k) Plan); and 225,625 shares of restricted common stock with restrictions releasing in equal annual increments over three- and four-year periods, held directly. |
4. See Footnote 3 for shares held directly and indirectly. |
5. Includes the following Table I Non-Derivative Securities: 5,000 shares held directly; 6,875 shares held indirectly by managed account (401(k) Plan); and 225,625 shares of restricted common stock with restrictions releasing in equal annual increments over three- and four-year periods, held directly. |
6. See Footnote 5 for shares held directly and indirectly. |
7. Includes the following Table I Non-Derivative Securities: 4,700 shares held directly; 6,875 shares held indirectly by managed account (401(k) Plan); and 225,625 shares of restricted common stock with restrictions releasing in equal annual increments over three- and four-year periods, held directly. |
8. See Footnote 7 for shares held directly and indirectly. |
9. Includes the following Table I Non-Derivative Securities: 4,600 shares held directly; 6,875 shares held indirectly by managed account (401(k) Plan); and 225,625 shares of restricted common stock with restrictions releasing in equal annual increments over three- and four-year periods, held directly. |
10. See Footnote 9 for shares held directly and indirectly. |
11. Includes the following Table I Non-Derivative Securities: 4,100 shares held directly; 6,875 shares held indirectly by managed account (401(k) Plan); and 225,625 shares of restricted common stock with restrictions releasing in equal annual increments over three- and four-year periods, held directly. |
12. See Footnote 11 for shares held directly and indirectly. |
13. Includes the following Table I Non-Derivative Securities: 3,700 shares held directly; 6,875 shares held indirectly by managed account (401(k) Plan); and 225,625 shares of restricted common stock with restrictions releasing in equal annual increments over three- and four-year periods, held directly. |
14. See Footnote 13 for shares held directly and indirectly. |
15. Includes the following Table I Non-Derivative Securities: 3,500 shares held directly; 6,875 shares held indirectly by managed account (401(k) Plan); and 225,625 shares of restricted common stock with restrictions releasing in equal annual increments over three- and four-year periods, held directly. |
16. See Footnote 15 for shares held directly and indirectly. |
17. Includes the following Table I Non-Derivative Securities: 2,600 shares held directly; 6,875 shares held indirectly by managed account (401(k) Plan); and 225,625 shares of restricted common stock with restrictions releasing in equal annual increments over three- and four-year periods, held directly. |
18. See Footnote 17 for shares held directly and indirectly. |
19. Includes the following Table I Non-Derivative Securities: 2,500 shares held directly; 6,875 shares held indirectly by managed account (401(k) Plan); and 225,625 shares of restricted common stock with restrictions releasing in equal annual increments over three- and four-year periods, held directly. |
20. See Footnote 19 for shares held directly and indirectly. |
21. Includes the following Table I Non-Derivative Securities: 1,900 shares held directly; 6,875 shares held indirectly by managed account (401(k) Plan); and 225,625 shares of restricted common stock with restrictions releasing in equal annual increments over three- and four-year periods, held directly. |
22. See Footnote 21 for shares held directly and indirectly. |
23. Includes the following Table I Non-Derivative Securities: 1,800 shares held directly; 6,875 shares held indirectly by managed account (401(k) Plan); and 225,625 shares of restricted common stock with restrictions releasing in equal annual increments over three- and four-year periods, held directly. |
24. See Footnote 23 for shares held directly and indirectly. |
25. Includes the following Table I Non-Derivative Securities: 1,500 shares held directly; 6,875 shares held indirectly by managed account (401(k) Plan); and 225,625 shares of restricted common stock with restrictions releasing in equal annual increments over three- and four-year periods, held directly. |
26. See Footnote 25 for shares held directly and indirectly. |
27. Includes the following Table I Non-Derivative Securities: 1,400 shares held directly; 6,875 shares held indirectly by managed account (401(k) Plan); and 225,625 shares of restricted common stock with restrictions releasing in equal annual increments over three- and four-year periods, held directly. |
28. See Footnote 27 for shares held directly and indirectly. |
29. Includes the following Table I Non-Derivative Securities: 1,200 shares held directly; 6,875 shares held indirectly by managed account (401(k) Plan); and 225,625 shares of restricted common stock with restrictions releasing in equal annual increments over three- and four-year periods, held directly. |
30. See Footnote 29 for shares held directly and indirectly. |
31. Includes the following Table I Non-Derivative Securities: 400 shares held directly; 6,875 shares held indirectly by managed account (401(k) Plan); and 225,625 shares of restricted common stock with restrictions releasing in equal annual increments over three- and four-year periods, held directly. |
32. See Footnote 31 for shares held directly and indirectly. |
33. Includes the following Table I Non-Derivative Securities: 300 shares held directly; 6,875 shares held indirectly by managed account (401(k) Plan); and 225,625 shares of restricted common stock with restrictions releasing in equal annual increments over three- and four-year periods, held directly. |
34. See Footnote 33 for shares held directly and indirectly. |
35. Includes the following Table I Non-Derivative Securities: 6,875 shares held indirectly by managed account (401(k) Plan); and 225,625 shares of restricted common stock with restrictions releasing in equal annual increments over three- and four-year periods, held directly. |
36. See Footnote 35 for shares held directly and indirectly. |
Remarks: |
CONTINUATION OF FORM 4 REPORTING SALES ON 11/01/2007 PURSUANT TO THE TERMS OF A RULE 10B5-1 TRADING PLAN ENTERED INTO ON SEPTEMBER 17, 2007. |
Dale B. Wolf | 11/05/2007 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |